摘要: Over the last decades therapy of rectal carcinoma has shown continuous improvement. Due to improvements in operative techniques, such as establishment total mesorectal excision (TME) and combination surgery (neo-) adjuvant radiochemotherapy, incidence locally recurrent cancer could be improved from nearly 50% less then 10%. Nevertheless remains a severe problem. Predictive factors relating are surgical experience, localization tumor, circumferential resection margins, stage-oriented multimodal suitable oncological procedure for primary tumor. In addition tumor-specific biology also seems relevant risk factor recurrence. Operative treatment was seen long time palliative procedure. Newer data show that can carried out with curative intention experienced institutions long-term 5 year survival about 30% mortality around 5%. The composite sacropelvic technique is reasonable option cancer. For future focus must on avoid local early diagnosis recurrence therapies will decisive importance.